Rituximab and Mycophenolate Mofetil in Interstitial Lung Disease (EVER-ILD): 1-year Follow-up Results of a Randomised Controlled Trial
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.